Kevin Alexander(@KMAlexanderMD) 's Twitter Profileg
Kevin Alexander

@KMAlexanderMD

Physician-scientist, advanced heart failure and transplant cardiologist, amyloidosis specialist

ID:984309471617757184

calendar_today12-04-2018 05:57:20

214 Tweets

705 Followers

450 Following

Jeff Teuteberg(@JeffTeuteberg) 's Twitter Profile Photo

Are you a current cardiology fellow interested in HF as a career? Apply for visiting fellowship Stanford University‼️ Experience customized to your clinical/research interests.
Kiran Khush HFSA The ISHLT TCC Community of Practice (TCC COP) - AST
Details & how to apply on the Stanford University_HF website:
med.stanford.edu/heartfailure/h…

account_circle
Michel Chedid El Helou, MD, MSc(@michel_helou) 's Twitter Profile Photo

Day 2: Full house at the Cardiac Amyloidosis session!

Had the honor of presenting our work on sex differences in ATTR-CM risk prediction.

Key takeaway:

➡️ Efforts to scale ATTR-CM diagnosis should be mindful of sex differences!

Trejeeve (Tre) Martyn Ronald Witteles Kevin Alexander

#ACC24 Day 2: Full house at the Cardiac Amyloidosis session! Had the honor of presenting our work on sex differences in ATTR-CM risk prediction. Key takeaway: ➡️ Efforts to scale ATTR-CM diagnosis should be mindful of sex differences! @tremartyn @Ron_Witteles @KMAlexanderMD
account_circle
Ahmad Masri(@MasriAhmadMD) 's Twitter Profile Photo

A lot more work is needed in V122I
Starting with identifying patients
Any Black patient >60 yo with heart failure and left ventricular hypertrophy requires active assessment. Dont stop at hypertension and/or kidney disease. Always explain LVH

account_circle
Hiesinger Lab(@HiesingerLab) 's Twitter Profile Photo

Our groundbreaking research on ‘Almanac: Retrieval Augmented Language Model for Clinical Medicine’ has just been published in NEJM AI. Check it out here: ai.nejm.org/stoken/default…

account_circle
Carlos G Santos-Gallego, MD(@SantosGallegoMD) 's Twitter Profile Photo

Very proud to be invited to lecture at about dual SGLT1/2 inhibition as a novel strategy for HFpEF!

Saturday 11/11 at 3.15-4.30pm to learn HFpEF therapies from amazing experts Muthu Vaduganathan @andrewjsauer Marat Fudim, MD MHS Sanjiv J. Shah, MD Kevin Alexander Jennifer Ho Ravi Patel

Very proud to be invited to lecture at #AHA2023 about dual SGLT1/2 inhibition as a novel strategy for HFpEF! Saturday 11/11 at 3.15-4.30pm to learn HFpEF therapies from amazing experts @mvaduganathan @andrewjsauer @FudimMarat @HFpEF @KMAlexanderMD @JenHoCardiology @RBPatelMD
account_circle
Sneha Shah Jain, MD, MBA(@SnehaShahJain) 's Twitter Profile Photo

We have had an allstar lineup of visiting grand rounds speakers this past month: Ajay Kirtane, Michel Haissaguerre, & Vivek Y. Reddy

Today, Stanford’s very own Victoria Parikh, MD, Josh Knowles, & Kevin Alexander present a fantastic talk on gene editing for CV disease StanfordCVFellowship

We have had an allstar lineup of visiting grand rounds speakers this past month: Ajay Kirtane, Michel Haissaguerre, & @VivekReddyMD Today, Stanford’s very own @vnparikh, @joshuawknowles, & @KMAlexanderMD present a fantastic talk on gene editing for CV disease @StanCVFellows
account_circle
Jon Pagtakhan(@JonPHeart) 's Twitter Profile Photo

Calling all basic and translational scientists/researchers‼️Join as a paid member before in our goal to be the largest Scientific Council by then! Reap the benefits as we support you and your science!
professional.heart.org/en/partners

Calling all basic and translational scientists/researchers‼️Join #BCVSCouncil as a paid member before #AHA23 in our goal to be the largest Scientific Council by then! Reap the benefits as we support you and your science! professional.heart.org/en/partners
account_circle
Heidi Salisbury(@NurseSalisbury) 's Twitter Profile Photo

Margaret Harris, PhD and Kevin Alexander impactful work demonstrating the learning gaps for clinicians when it comes to the dx and rx of cardiac amyloid in underserved pt populations

Margaret Harris, PhD and @KMAlexanderMD impactful work demonstrating the learning gaps for clinicians when it comes to the dx and rx of cardiac amyloid in underserved pt populations #HFSA2023 #cardiacamyloid #implementationscience
account_circle
Ronald Witteles(@Ron_Witteles) 's Twitter Profile Photo

(1/10) Today the long-awaited full results from the Phase 3 ATTRibute-CM trial were presented European Society of Cardiology . We already knew the topline results from last month: Acoramidis made a (big) difference in outcomes! What more did we learn?🤔Let's dig deeper...

(1/10) Today the long-awaited full results from the Phase 3 ATTRibute-CM trial were presented @escardio #ESCCongress. We already knew the topline results from last month: Acoramidis made a (big) difference in outcomes! What more did we learn?🤔Let's dig deeper...
account_circle